scholarly journals Quantitative proteomics analysis of early recurrence/metastasis of huge hepatocellular carcinoma following radical resection

2014 ◽  
Vol 12 (1) ◽  
pp. 22 ◽  
Author(s):  
Xinhui Huang ◽  
Yongyi Zeng ◽  
Xiaohua Xing ◽  
Jinhua Zeng ◽  
Yunzhen Gao ◽  
...  
2014 ◽  
Vol 67 (11) ◽  
pp. 974-979 ◽  
Author(s):  
Bo Xu ◽  
Zhixiong Cai ◽  
Yongyi Zeng ◽  
Lihong Chen ◽  
Xiaobo Du ◽  
...  

AimsHepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and it is still lacking effective prognostic biomarkers so far. Previous results of the iTRAQ-based quantitative proteomics study (iTRAQ-2DLC-MS/MS) have shown that α-methylacyl-CoA racemase (AMACR) might be a promising prognostic biomarker for the early recurrence/metastasis of hepatocellular carcinoma (HCC). Here a large-scale cohort clinical study was performed to evaluate its prognostic potential.MethodsHCC samples from patients (n=158) were used for the construction of tissue microarray. The expression level of AMACR was determined by immunohistochemical staining. A large-scale cohort clinical study between the expression of AMACR and some major clinical parameter has been performed to assess the prognostic potential of AMACR for the early recurrence/metastasis of HCC.ResultsSome important clinical parameters such as α-fetoprotein, tumour numbers, dissemination to regional lymph nodes, tumour capsule and portal vein tumour thrombosis are significantly associated with the low expression of AMACR. The expression of AMACR was an independent factor for the survival of patients with HCC. The median survival time was 17 months in the low-expression group compared with 45 months in the high-expression group.ConclusionsThis study reveals that the AMACR might be a potential prognostic marker for predicting early recurrence/metastasis of HCC after hepatectomy.


Oncotarget ◽  
2017 ◽  
Vol 8 (38) ◽  
pp. 63299-63310 ◽  
Author(s):  
Jiliang Feng ◽  
Junmei Chen ◽  
Ruidong Zhu ◽  
Lu Yu ◽  
Yan Zhang ◽  
...  

2020 ◽  
Author(s):  
Peng Liu ◽  
Yixiu Wang ◽  
Yuwei Xie ◽  
Luxun Zhang ◽  
Jinyu Pei ◽  
...  

Abstract BackgroundWe investigated the impact of elevated glucose levels on the early recurrence of hepatocellular carcinoma (HCC)after open radical hepatectomy.MethodsThis retrospective cohort study analyzed. The clinical data of 112 patients with hepatocellular carcinoma who underwent open radical hepatectomy from January 2013 to December 2014 at the Affiliated Hospital of Qingdao University. After radical resection of the hepatocellular carcinoma, 86 patients with an average fasting blood glucose(FBG) level of 3.9–6.1 mmol/L and 26 patients with an FBG level ≥ 6.1 mmol/L were divided into the normal group and hyperglycemic group, respectively. The recurrence rate of hepatocellular carcinoma was compared between the two groups 1 and 2 years after the operation.ResultsThe postoperative 1- and 2-year recurrence rates of HCC were 19.8% (17/86) and 33.7% (29/86), respectively, in the normal group and42.3% (11/26) and 61.5% (16/26), respectively, in the hyperglycemic group; there were significant differences between the two groups (χ2 = 6.719,P = 0.01;χ2 = 6.427༌P = 0.011). The univariate analysis showed that FBG, history of alcohol drinking, extent of hepatectomy, histopathological differentiation, maximal tumor diameter, satellite lesion, and the postoperative adjuvant treatment were risk factors affecting the tumor-free survival rate after open radical resection of hepatocellular carcinoma (P < .05).The results of the multivariate analysis showed that FBG levels ≥ 6.1 mmol/L, low histopathological differentiation, and no postoperative adjuvant treatment were independent risk factors affecting tumor-free survival rate after radical resection of hepatocellular carcinoma (P < .05).ConclusionAn elevated FBG level has a stimulating effect on the early recurrence of tumor after open radical resection of hepatocellular carcinoma. Therefore, postoperative monitoring and blood glucose control may facilitate a decrease in the early recurrence rate in patients with hepatocellular carcinoma.


2019 ◽  
Vol Volume 11 ◽  
pp. 2935-2946 ◽  
Author(s):  
Hongzhi Liu ◽  
Hui Chen ◽  
Xiaomo Wu ◽  
Ying Sun ◽  
Yingchao Wang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document